{"id":15438,"date":"2020-11-25T14:38:45","date_gmt":"2020-11-25T13:38:45","guid":{"rendered":"https:\/\/idibell.cat\/en\/?page_id=15438"},"modified":"2024-03-22T22:32:45","modified_gmt":"2024-03-22T21:32:45","slug":"ministry-cience-innovation-projects","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/ministry-cience-innovation-projects\/","title":{"rendered":"Ministry Science Innovation Projects"},"content":{"rendered":"\n<h5>\n\t\t&#8220;CONVOCATORIA  DE PROYECTOS DE I+D+i PARA LA REALIZACI\u00d3N DE \u00abPRUEBAS DE CONCEPTO\u00bb, EN EL MARCO DEL PROGRAMA ESTATAL DE I+D+i ORIENTADA A LOS RETOS DE LA SOCIEDAD, DEL PLAN ESTATAL DE INVESTIGACI\u00d3N CIENT\u00cdFICA Y T\u00c9CNICA Y DE INNOVACI\u00d3N 2017-2020. CONVOCATORIA 2021&#8221;\n\t<\/h5>\n\t<table width=\"1049\">\n<tbody>\n<tr>\n<td width=\"167\">Referencia<\/td>\n<td width=\"480\">Descripci\u00f3n<\/td>\n<td width=\"243\">INVESTIGADOR PRINCIPAL<\/td>\n<td width=\"159\">IMPORT FINAN\u00c7ABLE<\/td>\n<\/tr>\n<tr>\n<td>PDC2021-121308-I00<\/td>\n<td width=\"480\">DESARROLLO DE UN NUEVO BIOMARCADOR Y SU &#8216;KIT&#8217; PROTOTIPO PARA PREDECIR LA RESPUESTA AGRESIVA EN CANCER<\/td>\n<td>ORIOL CASANOVAS CASANOVAS<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 132.250,00 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/ODI2021.png\" alt=\"ODI2021\" itemprop=\"image\" height=\"99\" width=\"425\" title=\"ODI2021\" onerror=\"this.style.display='none'\"  \/>\n<h5>\n\t\t&#8220;CONVOCATORIA 2019 A \u00abPROYECTOS DE I+D+i\u00bb EN EL MARCO DE LOS PROGRAMAS ESTATALES DE  GENERACI\u00d3N DE CONOCIMIENTO Y FORTALECIMIENTO CIENT\u00cdFICO Y TECNOL\u00d3GICO DEL SISTEMA DE I+D+i Y DE I+D+i ORIENTADA A LOS RETOS DE LA SOCIEDAD.&#8221;\n\t<\/h5>\n\t<table width=\"1049\">\n<tbody>\n<tr>\n<td width=\"167\">Referencia<\/td>\n<td width=\"480\">Descripci\u00f3n<\/td>\n<td width=\"243\">INVESTIGADOR PRINCIPAL<\/td>\n<td width=\"159\">IMPORT FINAN\u00c7ABLE<\/td>\n<\/tr>\n<tr>\n<td>PID2019-107213GB-I00<\/td>\n<td width=\"480\">REGULACION DE LA MUERTE CELULAR, LA SECRECION DE CITOQUINAS Y LA PROGRESION DEL CANCER DE PULMON POR LA RUTA DE SE\u00d1ALIZACION DE ESTRES METABOLICO<\/td>\n<td>CRISTINA MU\u00d1OZ PINEDO<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 290.400,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2019-107557RB-I00<\/td>\n<td width=\"480\">TARGETEANDO LA COAGULACION EN LA FORMACION DE METASTASIS EN CANCER RENAL<\/td>\n<td>ORIOL CASANOVAS CASANOVAS<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 145.200,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2019-108580RA-I00<\/td>\n<td width=\"480\">ROL DE LA POLYADENILACION ALTERNATIVA EN LA DIFERENCIACION NEURONAL Y SU IMPLICACION EN EL DESARROLLO DE LA ENFERMEDAD DE ALZHEIMER A NIVEL DE CELULAS INDIVIDUALES<\/td>\n<td>MIREYA PLASS<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 143.748,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2019-111254RB-I00<\/td>\n<td width=\"480\">MODELANDO EL PRECANCER EN LA DEFICIENCIA REPARADORA DE APAREAMIENTOS ERRONEOS GERMINAL PARA UN SEGUIMIENTO PERSONALIZADO BASADO EN LA RESPUESTA IMMUNE<\/td>\n<td>GABRIEL CAPELL\u00c0 MUNAR<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 338.800,00 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/PID201920.png\" alt=\"PID201920\" itemprop=\"image\" height=\"100\" width=\"342\" title=\"PID201920\" onerror=\"this.style.display='none'\"  \/>\n<h5>\n\t\tCONVOCATORIA 2020 DE \u00abPROYECTOS DE I+D+i\u00bb EN EL MARCO DE LOS PROGRAMAS ESTATALES DE GENERACI\u00d3N DE CONOCIMIENTO Y FORTALECIMIENTO CIENT\u00cdFICO Y TECNOL\u00d3GICO DEL SISTEMA DE I+D+i Y DE I+D+i ORIENTADA A LOS RETOS DE LA SOCIEDAD.\n\t<\/h5>\n\t<table width=\"1049\">\n<tbody>\n<tr>\n<td width=\"167\">Referencia<\/td>\n<td width=\"480\">Descripci\u00f3n<\/td>\n<td width=\"243\">INVESTIGADOR PRINCIPAL<\/td>\n<td width=\"159\">IMPORT FINAN\u00c7ABLE<\/td>\n<\/tr>\n<tr>\n<td>PID2020-112595RB-I00<\/td>\n<td width=\"480\">TUMORES DEFICIENTES EN LA CORRECCION DE ERRORES DE LAS POLIMERASAS: PROFUNDIZANDO EN SUS BASES GENETICAS Y BIOLOGIA INMUNE PARA MEJORAR LAS RECOMENDACIONES CLINICAS<\/td>\n<td>LAURA VALLE VELASCO<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 393.250,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-113495RB-I00<\/td>\n<td width=\"480\">ESTUDIO DE NUEVAS ESTRATEGIAS TERAPEUTICAS PARA SUPRIMIR LA RESISTENCIA A TERAPIAS BASADAS EN EL BLOQUEO DE LOS PUNTOS DE CONTROL INMUNITARIOS\u00a0 (ICB) EN CSCC Y HNSCC AVANZADOS<\/td>\n<td>PURIFICACI\u00d3N MU\u00d1OZ MORUNO<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 223.850,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-114518RB-I00<\/td>\n<td width=\"480\">CARACTERIZACION Y POTENCIACIACION DE LAS INTERACCCIONES ENTRE LOS CIRCUITOS EMOCIONAL, MOTOR Y COGNITIVO CORTICO-ESTRIATALES<\/td>\n<td>ESTELA CAMARA MANCHA<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 121.000,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-114986RB-I00<\/td>\n<td width=\"480\">DEVELOPMENT OF CRISPR-CAS TECHNOLOGIES IN C. ELEGANS TO INVESTIGATE HUMAN PATHOGENIC MUTATIONS AND OTHER GENE VARIANTS, AND TO CREATE RARE DISEASE MODELS.<\/td>\n<td>JULIAN CERON MADRIGAL<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 139.150,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-115591RB-I00<\/td>\n<td width=\"480\">ESTUDIO DE LA TRANSFORMACION LEUCEMICA DE LA DEFICIENCIA DE GATA2 MEDIANTE TECNICAS \u0093OMICAS\u0094 EN MODELOS DE CELULAS MADRE HUMANAS<\/td>\n<td>ALESSANDRA GIORGETTI<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 121.000,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-117815RB-I00<\/td>\n<td width=\"480\">EL PERFIL METABOLICO COMO UNA OPORTUNIDAD TERAPEUTICA EN EL CANCER EPITELIAL DE OVARIO. IMPLICACIONES EN METASTASIS Y RESISTENCIA A LOS TRATAMIENTOS<\/td>\n<td>FRANCESC VI\u00d1ALS CANALS<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 217.800,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-119692RB-C21<\/td>\n<td width=\"480\">ADENOVIRUS ONCOLITICOS QUE EXPRESAN PROTEINAS FORMADORAS DE POROS PARA INDUCIR LA MUERTE INMUNOGENICA DE CELULAS TUMORALES<\/td>\n<td>RAMON ALEMANY BONASTRE<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 130.925,76 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/PID201920.png\" alt=\"PID201920\" itemprop=\"image\" height=\"100\" width=\"342\" title=\"PID201920\" onerror=\"this.style.display='none'\"  \/>\n<h5>\n\t\t &#8220;Convocatoria de 2021 de \u00abPROYECTOS DE GENERACI\u00d3N DE CONOCIMIENTO\u00bb en el marco del Programa Estatal para Impulsar la Investigaci\u00f3n Cient\u00edfico-T\u00e9cnica y su Transferencia, del Plan Estatal de Investigaci\u00f3n Cient\u00edfica, T\u00e9cnica y de Innovaci\u00f3n 2021-2023.&#8221;\n\t<\/h5>\n\t<table width=\"1049\">\n<tbody>\n<tr>\n<td width=\"167\">Referencia<\/td>\n<td width=\"480\">Descripci\u00f3n<\/td>\n<td width=\"243\">INVESTIGADOR PRINCIPAL<\/td>\n<td width=\"159\">IMPORT FINAN\u00c7ABLE<\/td>\n<\/tr>\n<tr>\n<td>PID2020-112595RB-I00<\/td>\n<td width=\"480\">TUMORES DEFICIENTES EN LA CORRECCION DE ERRORES DE LAS POLIMERASAS: PROFUNDIZANDO EN SUS BASES GENETICAS Y BIOLOGIA INMUNE PARA MEJORAR LAS RECOMENDACIONES CLINICAS<\/td>\n<td>LAURA VALLE VELASCO<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 393.250,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-113495RB-I00<\/td>\n<td width=\"480\">ESTUDIO DE NUEVAS ESTRATEGIAS TERAPEUTICAS PARA SUPRIMIR LA RESISTENCIA A TERAPIAS BASADAS EN EL BLOQUEO DE LOS PUNTOS DE CONTROL INMUNITARIOS\u00a0 (ICB) EN CSCC Y HNSCC AVANZADOS<\/td>\n<td>PURIFICACI\u00d3N MU\u00d1OZ MORUNO<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 223.850,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-114518RB-I00<\/td>\n<td width=\"480\">CARACTERIZACION Y POTENCIACIACION DE LAS INTERACCCIONES ENTRE LOS CIRCUITOS EMOCIONAL, MOTOR Y COGNITIVO CORTICO-ESTRIATALES<\/td>\n<td>ESTELA CAMARA MANCHA<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 121.000,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-114986RB-I00<\/td>\n<td width=\"480\">DEVELOPMENT OF CRISPR-CAS TECHNOLOGIES IN C. ELEGANS TO INVESTIGATE HUMAN PATHOGENIC MUTATIONS AND OTHER GENE VARIANTS, AND TO CREATE RARE DISEASE MODELS.<\/td>\n<td>JULIAN CERON MADRIGAL<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 139.150,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-115591RB-I00<\/td>\n<td width=\"480\">ESTUDIO DE LA TRANSFORMACION LEUCEMICA DE LA DEFICIENCIA DE GATA2 MEDIANTE TECNICAS \u0093OMICAS\u0094 EN MODELOS DE CELULAS MADRE HUMANAS<\/td>\n<td>ALESSANDRA GIORGETTI<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 121.000,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-117815RB-I00<\/td>\n<td width=\"480\">EL PERFIL METABOLICO COMO UNA OPORTUNIDAD TERAPEUTICA EN EL CANCER EPITELIAL DE OVARIO. IMPLICACIONES EN METASTASIS Y RESISTENCIA A LOS TRATAMIENTOS<\/td>\n<td>FRANCESC VI\u00d1ALS CANALS<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 217.800,00 \u20ac<\/td>\n<\/tr>\n<tr>\n<td>PID2020-119692RB-C21<\/td>\n<td width=\"480\">ADENOVIRUS ONCOLITICOS QUE EXPRESAN PROTEINAS FORMADORAS DE POROS PARA INDUCIR LA MUERTE INMUNOGENICA DE CELULAS TUMORALES<\/td>\n<td>RAMON ALEMANY BONASTRE<\/td>\n<td>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 130.925,76 \u20ac<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2024\/03\/PDC2021.png\" alt=\"PDC2021\" itemprop=\"image\" height=\"93\" width=\"499\" title=\"PDC2021\" onerror=\"this.style.display='none'\"  \/>\n<h2>\n\t\tRTC2019-007125-1 Project\n\t<\/h2>\n\t<p><strong>Coordinator: <\/strong>Senolytic Therapeutics, S.L.<\/p>\n<p><strong>IDIBELL Principal Investigator: <\/strong>Dra. Isabel Fabregat<\/p>\n<p><strong>Research group:<\/strong> TGF-beta and cancer (<a href=\"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/tgf-beta-and-cancer\/\" rel=\"noopener\" target=\"_blank\">link<\/a>)<\/p>\n<p><strong>Title: <\/strong>Desarrollo precl\u00ednico de un nuevo activo modulador de la fibrosis y la senescencia para el tratamiento de la enfermedad de h\u00edgado graso no alcoh\u00f3lico (HEPATOSEN)<\/p>\n<p><strong>Funding body: <\/strong> Ministerio de Ciencia e Innovaci\u00f3n, Programa Estatal de Investigaci\u00f3n Cient\u00edfica y T\u00e9cnica y de Innovaci\u00f3n 2017-2020.<\/p>\n<p><strong>Call: <\/strong>Subprograma RETOS-COLABORACI\u00d3N, Convocatoria 2019<\/p>\n<p><strong>Total grant amount: <\/strong>1.271.625,76 \u20ac<\/p>\n<p><strong>IDIBELL budget: <\/strong>159.287,29 \u20ac <\/p>\n\t\t\t\t<a href=\"http:\/\/www.lamoncloa.gob.es\/\" target=\"_blank\" rel=\"noopener\" itemprop=\"url\">\n\t\t\t\t<img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/idibell.cat\/en\/wp-content\/uploads\/sites\/2\/2020\/11\/MinisterioCeI.png\" alt=\"MinisterioCeI\" itemprop=\"image\" height=\"100\" width=\"517\" title=\"MinisterioCeI\" onerror=\"this.style.display='none'\"  \/>\n\t\t\t\t<\/a>\n\n","protected":false},"excerpt":{"rendered":"<p>&#8220;CONVOCATORIA DE PROYECTOS DE I+D+i PARA LA REALIZACI\u00d3N DE \u00abPRUEBAS DE CONCEPTO\u00bb, EN EL MARCO DEL PROGRAMA ESTATAL DE I+D+i ORIENTADA A LOS RETOS DE LA SOCIEDAD, DEL PLAN ESTATAL DE INVESTIGACI\u00d3N CIENT\u00cdFICA Y T\u00c9CNICA Y DE INNOVACI\u00d3N 2017-2020. CONVOCATORIA 2021&#8221; Referencia Descripci\u00f3n INVESTIGADOR PRINCIPAL IMPORT FINAN\u00c7ABLE PDC2021-121308-I00 DESARROLLO DE UN NUEVO BIOMARCADOR Y SU [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-15438","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2024-12-10 16:23:43","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/15438","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/comments?post=15438"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/15438\/revisions"}],"predecessor-version":[{"id":23828,"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/pages\/15438\/revisions\/23828"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/en\/wp-json\/wp\/v2\/media?parent=15438"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}